Related Experiment Videos
Morphine-induced thymic hypoplasia is glucocorticoid-dependent
Y Sei1, K Yoshimoto, T McIntyre
1Laboratory of Neuroscience, NIDDK, National Institutes of Health, Bethesda, MD 20892.
Journal of Immunology (Baltimore, Md. : 1950)
|January 1, 1991
Summary
Morphine significantly impacts thymocyte differentiation, reducing double-positive cells and increasing other subsets. This immune suppression in mice is linked to elevated corticosterone levels, suggesting a hormonal mediation of morphine
Area of Science:
- Immunology
- Endocrinology
- Pharmacology
Background:
- Opioid administration, such as morphine, can lead to thymic hypoplasia and suppressed T lymphocyte function.
- Understanding the specific effects of morphine on thymocyte differentiation is crucial for comprehending opioid-induced immunomodulation.
Purpose of the Study:
- To investigate the impact of morphine on thymocyte differentiation in mice.
- To elucidate the potential role of corticosterone in morphine-induced thymic changes.
Main Methods:
- Mice were administered morphine via subcutaneous pellet implantation.
- Flow cytometry was used to analyze thymocyte subsets (CD4, CD8, CD3, IL-2R).
- Serum corticosterone levels were measured, and the effects of dexamethasone and adrenalectomy were assessed.
Main Results:
- Morphine significantly decreased the number and proportion of CD4+/CD8+ double-positive (DP) thymocytes.
- Proportions of CD4+/CD8-, CD4-/CD8+, and CD4-/CD8- double-negative subsets increased proportionally.
- Morphine administration elevated serum corticosterone levels, and dexamethasone mimicked these effects.
- Adrenalectomy prevented the morphine-induced decrease in DP thymocytes.
Conclusions:
- Morphine-induced thymic hypoplasia and altered thymocyte differentiation are mediated, at least in part, by increased circulating corticosterone levels.
- These findings highlight the interplay between opioid use, the endocrine system, and immune function.